Calls for papers
-
Multistage cascade impaction is a core analytical technique for working with inhaled products, so understanding how cascade impactors work is crucial – but difficult. A new animation from impactor specialists Copley Scientific can help beginners… Read more . . .
-
Drawing on resources from the Lovelace Respiratory Research Institute (LRRI) and associated companies, a not-for-profit preclinical contract research organization called Lovelace Biomedical is now offering services for pre-clinical development. The new company’s services include toxicology,… Read more . . .
-
Mast Therapeutics has announced that its subsidiary Aires Pharmaceuticals has signed an agreement with Philips Respironics devices for the supply of I-neb AAD handheld nebulizers for delivery of the company’s AIR001 sodium nitrite solution. AIR001… Read more . . .
-
The FDA’s October 2016 release of new bioequivalence recommendations for specific products includes draft BE guidances for umeclidinium bromide inhalation powder (Incruse Ellipta), triamcinolone acetonide nasal spray (Nasacort), and olopatadine hydrochloride nasal spray (Patanase). For… Read more . . .
-
Drug delivery device design company Coalesce Product Development has announced the opening of a new 375 sq m drug delivery development center in Cambridge, UK as well as several management changes, including the appointment of… Read more . . .
-
The FDA has accepted Sunovion’s NDA for SUN-101 glycopyrrolate delivered by the PARI eFlow nebulizer for the treatment of COPD, the company said. The agency has set a PDUFA date of May 29, 2017 for… Read more . . .
-
Johnson & Johnson subsidiary Cilag GmbH International will pay a total of $330 million to AstraZeneca for rights to Rhinocort Aqua budesonide nasal spray outside of the US, AstraZeneca has announced. Cilag operates as part… Read more . . .
-
Aradigm Corporation has partnered with Professors Daniela Traini and Paul Young of the University of Sydney’s Woolcock Institute of Medical Research to develop an aerosol nanoparticle technology to combat fungal and bacterial biofilms. The project… Read more . . .
-
The Intelligent Control Inhaler from 3M Drug Delivery Systems has won the drug delivery devices category of the CPhI Pharma Awards. According to CPhI, the inhaler was recognized “for its approach to addressing patient adherence… Read more . . .
-
French device company Biocorp has announced the launch of its Inspair sensor, which it says is “capable of converting any pressurized metered dose inhaler into a connected device.” According to the company, the sensor works… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA